FITC Anti-CD4 抗体 [MEM-241]
FITC Anti-CD4 antibody [MEM-241]
Be the first to review this product! Submit a review
|
(3 Publications)
Anti-CD4 antibody [MEM-241] conjugated to FITC - suitable for flow cytometry, and reacts with human samples. Clone [MEM-241] is a mouse monoclonal antibody cited in 8 publications.
Design your panel with our interactive flow cytometry panel builder. Click here.
別名を表示する
CD4, T-cell surface glycoprotein CD4, T-cell surface antigen T4/Leu-3
- Flow Cyt
Unknown
Flow Cytometry - FITC Anti-CD4 antibody [MEM-241] (AB18281)
Overlay histogram showing peripheral blood lymphocytes stained with ab18281 (red line). The cells incubated in 1x PBS / 10% normal goat serum / 0.3M glycine to block non-specific protein-protein interactions. The cells were then incubated with the antibody (ab18281, 0.5 μg/1x106 cells) for 30 min at 22°C. Isotype control antibody (black line) was mouse IgG1 FITC (2 μg/1x106 cells ) for 30 min at 22°C. Acquisition of >5,000 events was performed.
関連する標識済み抗体及び組成の異なる製品 (7)
-
660 APC
APC Anti-CD4 antibody [MEM-241]
-
785 APC/Cy7®
APC/Cy7® Anti-CD4 antibody [MEM-241]
-
723 Alexa Fluor® 700
Alexa Fluor® 700 Anti-CD4 antibody [MEM-241]
-
Biotin Anti-CD4 antibody [MEM-241]
-
578 PE
PE Anti-CD4 antibody [MEM-241]
-
778 PE/Cy7®
PE/Cy7® Anti-CD4 antibody [MEM-241]
-
675 PerCP
PerCP Anti-CD4 antibody [MEM-241]
Reactivity data
出荷温度及び保存条件
製品の状態
精製方法
バッファー組成
出荷温度
短期保存温度
長期保存温度
製品プロトコール
- Visit the General protocols
- Visit the Troubleshooting
ターゲットの情報
文献 (3)
Recent publications for all applications. Explore the full list and refine your search
BMC immunology 23:58 PubMed36434505
2022
Applications
Unspecified application
Species
Unspecified reactive species
Cancer cell international 21:58 PubMed33468159
2021
Applications
Unspecified application
Species
Unspecified reactive species
eLife 9: PubMed32441251
2020
Applications
Unspecified application
Species
Unspecified reactive species
Abcam product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com